Munafa Stock Market Course + Intraday & FNO calls 
Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)
Technical Analysis Report for NASDAQ stock BOLD Audentes Therapeutics. Dated: 09 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics
Audentes Therapeutics Opened at 1.18 and Closed at: 1.15, which is -0.87% of previous session's close. It moved within a range of 1.13 and 1.20
The session was a Bearish session with an average volume of 105600, which is -169.89% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
A Dead cross was found 8 days back on short term averages
A Dead cross was found 4 days back on mid term averages
A Dead cross was found 6 days back on long term averages
Support for tomorrow is 1.11 and resistance for tomorrow is 1.18
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.12, 1.09 resistance for tomorrow's hourly charts is 1.19, 1.23
10 Day SMA for Audentes Therapeutics (BOLD) is 1.14 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Audentes Therapeutics (BOLD) is 1.19 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Audentes Therapeutics (BOLD) is 1.19 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.23 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Audentes Therapeutics is 1.23 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Audentes Therapeutics is at 1.19 and 200 DMA is at 1.23, while 50 DMA and 100 DMA are at 1.19 and 1.23 respectively
Audentes Therapeutics (BOLD) moving average of 20 SMA is at 1.19 and 20 EMA is at 1.17
| Date | Closing Price | 20 SMA | 20 EMA |
| 09 Mon Feb | 1.15 | 1.19 | 1.17 |
| 06 Fri Feb | 1.16 | 1.2 | 1.17 |
| 05 Thu Feb | 1.09 | 1.21 | 1.17 |
| 04 Wed Feb | 1.05 | 1.22 | 1.18 |
| 03 Tue Feb | 1.08 | 1.23 | 1.19 |
| 02 Mon Feb | 1.13 | 1.23 | 1.2 |
Audentes Therapeutics (BOLD) moving average of 50 SMA is at 1.19 and 50 EMA is at 1.2
| Date | Closing Price | 50 SMA | 50 EMA |
| 09 Mon Feb | 1.15 | 1.19 | 1.2 |
| 06 Fri Feb | 1.16 | 1.19 | 1.2 |
| 05 Thu Feb | 1.09 | 1.19 | 1.2 |
| 04 Wed Feb | 1.05 | 1.19 | 1.2 |
| 03 Tue Feb | 1.08 | 1.19 | 1.21 |
| 02 Mon Feb | 1.13 | 1.19 | 1.22 |
Audentes Therapeutics (BOLD) moving average of 100 SMA is at 1.23 and 100 EMA is at 1.32
| Date | Closing Price | 100 SMA | 100 EMA |
| 09 Mon Feb | 1.15 | 1.23 | 1.32 |
| 06 Fri Feb | 1.16 | 1.23 | 1.32 |
| 05 Thu Feb | 1.09 | 1.23 | 1.32 |
| 04 Wed Feb | 1.05 | 1.23 | 1.32 |
| 03 Tue Feb | 1.08 | 1.23 | 1.33 |
| 02 Mon Feb | 1.13 | 1.23 | 1.33 |
Audentes Therapeutics (BOLD) moving average of 200 SMA is at 1.23 and 200 EMA is at 1.57
| Date | Closing Price | 200 SMA | 200 EMA |
| 09 Mon Feb | 1.15 | 1.23 | 1.57 |
| 06 Fri Feb | 1.16 | 1.23 | 1.57 |
| 05 Thu Feb | 1.09 | 1.23 | 1.57 |
| 04 Wed Feb | 1.05 | 1.24 | 1.57 |
| 03 Tue Feb | 1.08 | 1.24 | 1.58 |
| 02 Mon Feb | 1.13 | 1.24 | 1.59 |
Dentsply Sirona has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 16.77% more returns!
Verastem Inc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Verastem Inc, about 0.79% more returns!
Spero Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Spero Therapeutics, about 1.28% more returns!
Audentes Therapeutics has performed better than Repligen Corporation in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Marker Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Medpace Holdings in short term. Holding Audentes Therapeutics could be a better choice for now!
Moleculin Biotech has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 8.99% more returns!
Livanova Plc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Livanova Plc, about 12.65% more returns!
Lakeland Industries has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Lakeland Industries, about 15.01% more returns!
Audentes Therapeutics has performed better than Kodiak Sciences in short term. Holding Audentes Therapeutics could be a better choice for now!
Abeona Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 7.85% more returns!
Acadia Healthcare has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 9.23% more returns!
Aquestive Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 19.51% more returns!
Audentes Therapeutics has performed better than Aytu Bioscience in short term. Holding Audentes Therapeutics could be a better choice for now!
Cerus Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Cerus Corporation, about 2.46% more returns!
Collegium Pharmaceutical has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 3.38% more returns!
Delcath Systems has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Delcath Systems, about 3.96% more returns!
Audentes Therapeutics Technical analysis of indicators
Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term and the sell signal is strong.
Audentes Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Audentes Therapeutics in short term
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Audentes Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.13 and Audentes Therapeutics BOLD stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BOLD Experts View which covers a lot of information including buying and selling signals
BOLD future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
